The results showed the suppression of miR-96-5p could relieve IDD by activating the PPARγ/NF-κB signaling pathway, indicating miR-96-5p may be a promising target for IDD treatment. The gene discussed is NFKB1; the disease is intervertebral disk degenerative disorder.